May 3 |
NovoCure Limited Q1 Earnings: Core Business Accelerating
|
May 3 |
NovoCure Limited (NASDAQ:NVCR) Q1 2024 Earnings Call Transcript
|
May 3 |
NovoCure (NVCR) Q1 2024 Earnings Call Transcript
|
May 2 |
NovoCure Limited (NVCR) Q1 2024 Earnings Call Transcript
|
May 2 |
NovoCure Limited 2024 Q1 - Results - Earnings Call Presentation
|
May 2 |
NovoCure Ltd (NVCR) Q1 2024 Earnings: Revenue Surpasses Estimates, Narrower Net Loss Reported
|
May 2 |
NovoCure (NVCR) Reports Q1 Loss, Tops Revenue Estimates
|
May 2 |
Novocure secures new $400M multi-tranche debt financing, shares up
|
May 2 |
NovoCure GAAP EPS of -$0.36 beats by $0.06, revenue of $138.5M beats by $7.05M
|
May 2 |
Novocure Secures New $400 Million Multi-Tranche Non-Dilutive Debt Financing from Pharmakon
|